Gain high value access and increase the profitability of your brands
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSIQVIA's Market Access Center of Excellence conducted a cross-sectional, 12-month study to examine whether 340B discounts are directly shared with patients, examining the impact of 340B eligibility on patient out-of-pocket costs at contract pharmacies. This white paper discusses the research findings regarding how much benefit is flowing directly to patients.
Download the Fact Sheet for a summary of the research. For full details of the research, please read the white paper here.
Gain high value access and increase the profitability of your brands
Rely on market-leading strategists to help you achieve maximum access and profitability